ABCC7 p.Pro1021Ala

ClinVar: c.3061C>T , p.Pro1021Ser ? , not provided
CF databases: c.3061C>G , p.Pro1021Ala (CFTR1) D ,
c.3061C>T , p.Pro1021Ser (CFTR1) D , The P1021S mutation has been detected by SSCA and direct sequencing. The mutation was identified in a Spanish man with CBAVD carrying a [delta]F508 on the other chromosome.
Predicted by SNAP2: A: N (57%), C: N (53%), D: D (80%), E: D (85%), F: D (66%), G: D (63%), H: D (80%), I: D (59%), K: D (85%), L: D (59%), M: D (80%), N: D (75%), Q: D (80%), R: D (91%), S: D (59%), T: D (66%), V: N (57%), W: D (85%), Y: D (80%),
Predicted by PROVEAN: A: D, C: D, D: D, E: D, F: D, G: D, H: D, I: D, K: D, L: D, M: D, N: D, Q: D, R: D, S: D, T: D, V: D, W: D, Y: D,

[switch to compact view]
Comments [show]
Publications
[hide] Sheppard DN, Travis SM, Ishihara H, Welsh MJ
Contribution of proline residues in the membrane-spanning domains of cystic fibrosis transmembrane conductance regulator to chloride channel function.
J Biol Chem. 1996 Jun 21;271(25):14995-5001., [PMID:8663008]

Abstract [show]
Comments [show]
Sentences [show]